- China Agrees to Open Up Market for Indian Drugmakers (PharmaTimes)
- A Fibromyalgia Drug That Improves Sleep Quality More Than Pfizer’s Lyrica Would Earn Sizeable Patient Share in the U.S. and Europe (PR Newswire)
- Alcon Investor Expects Novartis to Raise Offer (Reuters)
- EMA’s First “compassionate use” Opinion is for Tamiflu (PharmaTimes)
- Genzyme’s Lumizyme BLA Gets Six-Month US FDA Review Timeframe (PharmaBiz)
- US Orphan Drug Numbers Have Soared, Says New Study (PharmaTimes)
- Japanese Pharma Market Growth Set to Plummet (PharmaTimes)
- Teva Increases Lobbying Ahead Of US Reform (PharmaLive)
- US FDA to Convene Public Meeting on Feb 18 on Premarket Clearance Process for Medical Devices (PharmaBiz)
- GSK/Genmab’s Arzerra wins EU Backing for Leukaemia (PharmaTimes)
SUBSCRIBE